Gelteq Limited Ordinary Shares (GELS) Stock Analysis & Winston Score

Gelteq is a small Australian company that makes soft gel chewable products for delivering vitamins, supplements, and pharmaceutical ingredients. Instead of traditional pills or tablets, Gelteq's technology puts active ingredients into a gummy-like gel format that is easier to swallow and can taste better. The company serves supplement brands, pharmaceutical companies, and consumer health markets. Gelteq earns revenue by manufacturing gel products for other companies and by licensing its proprietary gel delivery technology. It is a micro-cap company based in Australia with operations still in early commercial stages. The company's 100% gross margin figure reflects its early-stage nature with minimal direct production costs reported, while deeply negative operating margins show it spends far more on development and overhead than it currently earns. The key growth driver is winning manufacturing contracts and licensing deals, but the main risk is that the company remains unprofitable and may need additional funding to sustain operations.